Peter Buggisch

13.1k citations
236 papers · 10.2k · 5 hit papers · h-index 38

Impact in

  • Hepatology top 0.1%
    • Hepatitis C virus research
    • Liver Diseases and Immunity
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Epidemiology top 0.5%
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Hepatitis C virus research 155
    • Liver Diseases and Immunity 9
    • Liver Disease and Transplantation 8
    • Hepatocellular Carcinoma Treatment and Prognosis 6
    • Hepatitis B Virus Studies 37
    • Liver Disease Diagnosis and Treatment 14

Peter Buggisch

221 papers receiving 9.7k citations

Peter Buggisch's Hit Papers

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis 2024 · 167 citations
1670+6+12Years since publication4008001.2k

Peers

Peter Buggisch
Comparison fields: 5 of 116
  • Hepatology 5.1k
  • Epidemiology 3.3k
  • Oncology 566
  • Immunology 322
  • Radiology, Nuclear Medicine and Imaging 357
Replace William Sievert with:
William Sievert Australia
E. Jenny Heathcote Canada
Maria Grazia Rumi Italy
Robert Reindollar United States
Anaïs Vallet‐Pichard France
Stephanos J. Hadziyannis Greece
Chuan–Mo Lee Taiwan
Ed J. Gane New Zealand
Nancy W.Y. Leung China
Pierluigi Toniutto Italy
Peter Buggisch relative to William Sievert Australia William Sievert's profile →
Citations per field
00.5×2×2.7×
William Sievert · 1×
Citations per year

Countries citing papers authored by Peter Buggisch

Since Specialization
Citations

This map shows the geographic impact of Peter Buggisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Buggisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Buggisch more than expected).

Fields of papers citing papers by Peter Buggisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Buggisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Buggisch. The network helps show where Peter Buggisch may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Buggisch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Buggisch Line = papers co-authored together Peter Buggisch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 236 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Hit paper breakdown →
20141454
2
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Hit paper breakdown →
2008970
3 1994531
4
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Hit paper breakdown →
2012485
5
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
2003464
6
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Hit paper breakdown →
2017453
7 1998431
8 2010399
9 2006391
10 2006380
11 2009286
12 1993213
13 2006172
14
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
Hit paper breakdown →
2024167
15 2017166
16 2008155
17 2017134
18 2019127
19 2011116
20 2011107

About Peter Buggisch

Peter Buggisch is a scholar working on Hepatology, Epidemiology, Oncology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 236 papers that have together received 10.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (155 papers), Hepatitis B Virus Studies (37 papers), Liver Disease Diagnosis and Treatment (14 papers), Liver Diseases and Immunity (9 papers), Liver Disease and Transplantation (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Ultrasound Imaging and Elastography (3 papers). The work is most often cited by research in Hepatology (5.1k citations), Epidemiology (3.3k citations), Oncology (566 citations), Immunology (322 citations) and Radiology, Nuclear Medicine and Imaging (357 citations). Peter Buggisch has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Thomas Berg, Stefan Zeuzem, Christoph Sarrazin, Heiner H. Wedemeyer, Wolff Schmiegel, Hartwig Klinker, Rudolf Gruber, Jens Witte, R. Pichlmayr and K. Höffken. Their work appears in journals such as Journal of Hepatology, Hepatology, Liver International, Gastroenterology and Journal of Viral Hepatitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact